v3.25.2
Consolidated Statements of Cash Flow - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (4,240,109) $ (1,707,481)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 1,374 1,832
Stock-based compensation 3,512,500 977,235
Conversion of liabilities into common stock 19,335
Late fee capitalized into notes payable 90,000 120,000
Loss on debt settlement 5,000 105,000
Common stock issued for interest expense 6,447
Effects of the elimination of the beneficial conversion feature 150,556
Beneficial conversion feature 30,111
Changes in assets and liabilities:    
Prepaid expenses 1,331 (21,975)
Prepaid costs for reverse capitalization 150,000
Other current assets (2,000) 2,000
Receivables from related parties 2,053
Accounts payable and accrued expenses 139,139 (304,437)
USDA CRADA liability (246,400)
Due to related party 3,846 26,154
Net cash used in operating activities (553,235) (871,734)
Cash flows from financing activities:    
Proceeds from notes payable 300,000 265,000
Proceeds from sale of common stock 165,000 354,702
Net cash provided by financing activities 465,000 619,702
Net decrease in cash (88,235) (252,032)
Cash at beginning of period 384,621 296,386
Cash at end of period 296,386 44,354
Cash paid for interest
Cash paid for taxes
Non-cash investing and financing activities:    
Discount on notes payable 269,916
Conversion of note payable into common stock 1,235,555 76,325
Conversion of liabilities into common stock 19,303
Conversion of notes payable into warrants 350,000
Issuance of common stock for debt settlement 49,725
Fundraising services 170,000
Fund
Prepaid costs for reverse capitalization recognized in additional paid-in capital $ 150,000